HomeORIC • NASDAQ
add
ORIC Pharmaceuticals Inc
Previous close
$13.40
Day range
$12.77 - $13.67
Year range
$3.90 - $14.93
Market cap
1.35B USD
Avg Volume
1.81M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 34.55M | -12.68% |
Net income | -30.50M | 15.98% |
Net profit margin | — | — |
Earnings per share | -0.30 | 41.18% |
EBITDA | -34.23M | 12.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 281.49M | 9.97% |
Total assets | 408.89M | 49.15% |
Total liabilities | 24.53M | -20.93% |
Total equity | 384.36M | — |
Shares outstanding | 100.36M | — |
Price to book | 3.44 | — |
Return on assets | -20.56% | — |
Return on capital | -21.43% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -30.50M | 15.98% |
Cash from operations | -22.48M | 19.86% |
Cash from investing | 16.98M | -60.18% |
Cash from financing | 1.50M | 160.87% |
Net change in cash | -4.00M | -126.35% |
Free cash flow | -13.54M | 10.57% |
About
Founded
2014
Headquarters
Website
Employees
104
